{"id":"W4298144359","doi":"10.51731/cjht.2022.458","title":"Selpercatinib (Retevmo)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Science, Research, and Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Lenvatinib; Reimbursement; Medicine; Sorafenib; Drug; Thyroid cancer; Thyroid carcinoma; Oncology; Intensive care medicine; Internal medicine; Family medicine; Thyroid; Pharmacology; Political science; Health care","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003600289,0.0002573612,0.0002659814,0.0006082513,0.0001580436,0.0005975868,0.0003055988,0.0003294412,0.01007043],"category_scores_gemma":[0.0004258533,0.00006050242,0.0004049107,0.0004038627,0.0001936133,0.000434639,0.0002653512,0.0004761946,0.002800103],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001003152,"about_ca_system_score_gemma":0.0009941633,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003905794,"about_ca_topic_score_gemma":0.01820613,"domain_scores_codex":[0.9998287,0.000034838,0.00001981465,0.00002949014,0.00006374915,0.00002334877],"domain_scores_gemma":[0.9998696,0.00002787696,0.00003601312,0.00000519324,0.00004169204,0.00001957768],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005610519,0.00006611705,0.0008225705,0.00281351,0.00018777,0.000162319,0.00003265159,0.0003404051,0.006373958,0.00277803,0.07354529,0.9123163],"study_design_scores_gemma":[0.0003861777,0.0009525169,0.004774686,0.001354573,0.0002680826,0.001485232,0.00005273616,0.0003135007,0.00915871,0.0008709723,0.9803582,0.00002463035],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.04696578,0.7443618,0.002610883,0.0108804,0.001713863,0.0003434873,0.005453569,0.0007104229,0.1869597],"genre_scores_gemma":[0.3639412,0.4881376,0.00450268,0.01164101,0.0007278949,0.000263574,0.009363431,0.00007563949,0.1213469],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.01007043,"threshold_uncertainty_score":0.03368896,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05854083048312315,"score_gpt":0.3495056216524716,"score_spread":0.2909647911693484,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}